It is associated with increased BDNF activity, improved cerebral blood flow, and enhanced cognitive resilience
In the initial stages of treatment, you may still feel hungry or experience cravings, as the medication begins to regulate your appetite
Travel considerations Traveling with semaglutide requires maintaining the cold chain
participants achieved a mean weight loss of approximately 2.2 kg at 12 months [10]
Three medications represent this progression: Semaglutide (single agonist, 15% average weight loss), Tirzepatide (dual agonist, 22.5% weight loss), and Retatrutide (triple agonist, 28.7% weight loss)
Thanks to telemedicine, its easier than ever to consult with a healthcare provider from the comfort of your home